Pyrrolo [1,2-F][1,2,4] Triazin-4-Amine CAS 159326-68-8 Remdesivir Entèmedyè COVID-19
Manifakti Komèsyal Pwovizyon pou Remdesivir ak entèmedyè ki gen rapò ak kalite siperyè
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilil Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutil ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir metabolit (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Entèmedyè CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo [2,1-f][1,2,4] triazin-4-amine CAS 937046-98-5
Pyrrolo [1,2-F][1,2,4] Triazin-4-Amine CAS 159326-68-8
4-Amino-7-yodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Non Chimik | Pyrrolo [1,2-F][1,2,4] Triazin-4-Amine |
Sinonim | 4-Aminopyrrolo [2,1-f][1,2,4] triazin;Remdesivir Entèmedyè |
Nimewo CAS | 159326-68-8 |
Nimewo CAT | RF-PI302 |
Estati Stock | Nan stock, pwodiksyon echèl jiska dè santèn de kilogram |
Fòmil molekilè | C6H6N4 |
Pwa molekilè | 134.14 |
Dansite | 1.50 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Off-White Powder |
Enfrawouj Spectrum | Konfòm ak estrikti |
Pite | ≥99.0% |
Pèt sou siye | ≤0.50% |
Single enpurte | ≤0.50% |
Enpurte total | ≤1.0% |
Metal lou | ≤20ppm |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Remdesivir (CAS 1809249-37-3) |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
Shanghai Ruifu Chemical Co, Ltd se dirijan manifakti ak founisè Pyrrolo [1,2-F][1,2,4] Triazin-4-Amine (CAS 159326-68-8) ak kalite siperyè.Li se yon entèmedyè nan Remdesivir (CAS 1809249-37-3).Remdesivir se yon prodrog antiviral laj ki montre aktivite antiviral kont coronavirus SARS, coronavirus MERS ak, pi resamman, Covid-19.Remdesivir (GS-5734), yon analogue nukleozid ak aktivite antiviral efikas, gen EC50s de 74 nM pou SARS-CoV ak MERS-CoV nan selil HAE, ak 30 nM pou viris epatit murin nan selil timè nan sèvo reta.Remdesivir trè efikas nan kontwòl enfeksyon SARS-CoV-2 (COVID-19) nan vitro.